Oppenheimer analyst, Leland Gershell, reiterated an Outperform rating on Evofem Biosciences Inc (NASDAQ: EVFM) and raised the price target to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE